Thursday, November 5, 2009

DCGI asks DTAB to re-examine many widely marketed drugs including Nimesulide

Several controversial drugs, which are banned in the developed nations like US, Canada and European Union nations for adverse health effects and are freely available in India, will be re-examined by the Drugs Technical Advisory Board (DTAB) in its meeting on November 9.

The details can be read here.

No comments: